Catyalyst Pharma (CPRX) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS ex-items of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Reservoir Media, Inc. (RSVR) Tops Q2 EPS by 2c; offers guidance
- Avnet (AVT) Tops Q1 EPS by 97c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
